ZEGA Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.96M Sell
6,635
-1,168
-15% -$1.19M 0.82% 23
2026
Q1
$7.18M Buy
7,803
+147
+2% +$149K 0.81% 23
2025
Q4
$8.23M Buy
7,656
+1,048
+16% +$1M 0.97% 21
2025
Q3
$5.04M Buy
6,608
+132
+2% +$98.2K 0.67% 25
2025
Q2
$5.05M Buy
6,476
+4,764
+278% +$3.7M 0.69% 25
2025
Q1
$1.41M Sell
1,712
-6
-0.3% -$4.99K 0.22% 59
2024
Q4
$1.35M Buy
+1,718
New +$1.42M 0.34% 41

Other funds holding LLY

ZEGA Investments's LLY Position: Q2 2026 in Review

ZEGA Investments reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $1.19M and leaving 6,635 shares worth $7.96M. The position accounts for 0.82% of the portfolio, ranked #23.

ZEGA Investments first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.23M in Q4 2025. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ZEGA Investments held 6,635 shares of Eli Lilly worth $7.96M as of Q2 2026.
  • ZEGA Investments sold 1,168 Eli Lilly shares in Q2 2026, an estimated $1.19M.
  • Eli Lilly made up 0.82% of ZEGA Investments's portfolio in Q2 2026, its #23 holding.
  • ZEGA Investments first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • ZEGA Investments's Eli Lilly position peaked at $8.23M in Q4 2025.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ZEGA Investments's 13F filing for Q2 2026, filed 31 Jul 2026.